Status:
TERMINATED
PrEP and Consumptions
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Psychoactive Substance Use
Mood Disorders
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
HIV pre-exposure prophylaxis (PrEP) with Truvada®, a combination of two antiretrovirals (tenofovir \& emtricitabine) is a prevention strategy for HIV-negative people at high risk of acquiring HIV. PrE...
Detailed Description
Interventional, multi-center pilot study, including all subjects aged 18 years or older presenting in consultation for a PrEP renewal. The newsletter and a self-questionnaire will be systematically g...
Eligibility Criteria
Inclusion
- Subject aged over 18,
- Subject seen in consultation in one of the centers of the study for a renewal of the Prep
- Subject having agreed to participate in the study
Exclusion
- Subject not speaking French / illiterate
Key Trial Info
Start Date :
January 3 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 3 2019
Estimated Enrollment :
237 Patients enrolled
Trial Details
Trial ID
NCT03449771
Start Date
January 3 2018
End Date
November 3 2019
Last Update
December 30 2021
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital of Alès
Alès, France, 30100
2
Uh Montpellier
Montpellier, France, 34090
3
CEGIDD
Nîmes, France, 30900
4
UH NIMES
Nîmes, France, 30900